抑制剂:
4930564B18Rik, AARD, AChRα9, Alsin, Aspartoacylase-3, Ataxin-2, C230078M14Rik, CaBP4, Caytaxin, Cerebellin 1, Cerebellin 4, CNG-1β, Complexin-1, CYP1A2, EG632778, ERICH1, FAM194B, FAM69A, GABA T-2, GLUD2, GluR-δ1, GluR-δ2, GlyR β, GRIN1, GRIN2, GRIN3, IGSF9, KV6.3, LEP503, Lingo-3, LRFN5, LRRC8D, Mas 7, mGluR-1, mGluR-6, Mover, N-methyl-D-aspartate (NMDA; GRIN) receptor, Na+ CP type IIIα, Na+ CP type IVα, NCDN, Neu, Neuritin, NF-H, NgR3, NLF1, NMDA zeta 1, NTAL, Olfr824, Olr540, Polycystin-2, Renalase, Rit2, ROG, Serine racemase, Shank2, SLC17A (solute carrier family 17), SLC17A2, SLC38A8, SLC6A (solute carrier family 6), SLC7A12, SNAT1, Sodium Channel Protein, sodium channel type I, sodium channel type II, sodium channel type III, sodium channel type IV, SPBP, SYCE3, Tau, TMEM175, TRESK, Unc79, VGAT, Vmn2r122, Vmn2r33, Vmn2r4, Vmn2r61, 和 Vmn2r94.